These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 25989143)

  • 41. Activation of glutamate neurotransmission in the prefrontal cortex sustains the motoric and dopaminergic effects of phencyclidine.
    Takahata R; Moghaddam B
    Neuropsychopharmacology; 2003 Jun; 28(6):1117-24. PubMed ID: 12700703
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Ionotropic glutamate receptors and expression of N-methyl-D-aspartate receptor subunits in subregions of human hippocampus: effects of schizophrenia.
    Gao XM; Sakai K; Roberts RC; Conley RR; Dean B; Tamminga CA
    Am J Psychiatry; 2000 Jul; 157(7):1141-9. PubMed ID: 10873924
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Glutamate-stimulated release of norepinephrine in hippocampal slices of animal models of attention-deficit/hyperactivity disorder (spontaneously hypertensive rat) and depression/anxiety-like behaviours (Wistar-Kyoto rat).
    Howells FM; Russell VA
    Brain Res; 2008 Mar; 1200():107-15. PubMed ID: 18295191
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Ketamine modulates hippocampal neurochemistry and functional connectivity: a combined magnetic resonance spectroscopy and resting-state fMRI study in healthy volunteers.
    Kraguljac NV; Frölich MA; Tran S; White DM; Nichols N; Barton-McArdle A; Reid MA; Bolding MS; Lahti AC
    Mol Psychiatry; 2017 Apr; 22(4):562-569. PubMed ID: 27480494
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Ketamine-Induced Modulation of the Thalamo-Cortical Network in Healthy Volunteers As a Model for Schizophrenia.
    Höflich A; Hahn A; Küblböck M; Kranz GS; Vanicek T; Windischberger C; Saria A; Kasper S; Winkler D; Lanzenberger R
    Int J Neuropsychopharmacol; 2015 Apr; 18(9):. PubMed ID: 25896256
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Spontaneous recurrent network activity in organotypic rat hippocampal slices.
    Mohajerani MH; Cherubini E
    Eur J Neurosci; 2005 Jul; 22(1):107-18. PubMed ID: 16029200
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The acute effects of NMDA antagonism: from the rodent to the human brain.
    Gunduz-Bruce H
    Brain Res Rev; 2009 May; 60(2):279-86. PubMed ID: 18703087
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cerebroside-A provides potent neuroprotection after cerebral ischaemia through reducing glutamate release and Ca²⁺ influx of NMDA receptors.
    Li L; Yang R; Sun K; Bai Y; Zhang Z; Zhou L; Qi Z; Qi J; Chen L
    Int J Neuropsychopharmacol; 2012 May; 15(4):497-507. PubMed ID: 21557879
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Early modifications in N-methyl-D-aspartate receptor subunit mRNA levels in an oxygen and glucose deprivation model using rat hippocampal brain slices.
    Dos-Anjos S; Martínez-Villayandre B; Montori S; Pérez-García CC; Fernández-López A
    Neuroscience; 2009 Dec; 164(3):1119-26. PubMed ID: 19761817
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Activation of dopaminergic neurotransmission in the medial prefrontal cortex by N-methyl-d-aspartate stimulation of the ventral hippocampus in rats.
    Peleg-Raibstein D; Pezze MA; Ferger B; Zhang WN; Murphy CA; Feldon J; Bast T
    Neuroscience; 2005; 132(1):219-32. PubMed ID: 15780480
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The linoleic acid derivative FR236924 facilitates hippocampal synaptic transmission by enhancing activity of presynaptic alpha7 acetylcholine receptors on the glutamatergic terminals.
    Yamamoto S; Kanno T; Nagata T; Yaguchi T; Tanaka A; Nishizaki T
    Neuroscience; 2005; 130(1):207-13. PubMed ID: 15561436
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Acute p38-mediated inhibition of NMDA-induced outward currents in hippocampal CA1 neurons by interleukin-1beta.
    Zhang R; Sun L; Hayashi Y; Liu X; Koyama S; Wu Z; Nakanishi H
    Neurobiol Dis; 2010 Apr; 38(1):68-77. PubMed ID: 20060906
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Glutamatergic aspects of schizophrenia.
    Tamminga C
    Br J Psychiatry Suppl; 1999; (37):12-5. PubMed ID: 10211134
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Glutaminase-deficient mice display hippocampal hypoactivity, insensitivity to pro-psychotic drugs and potentiated latent inhibition: relevance to schizophrenia.
    Gaisler-Salomon I; Miller GM; Chuhma N; Lee S; Zhang H; Ghoddoussi F; Lewandowski N; Fairhurst S; Wang Y; Conjard-Duplany A; Masson J; Balsam P; Hen R; Arancio O; Galloway MP; Moore HM; Small SA; Rayport S
    Neuropsychopharmacology; 2009 Sep; 34(10):2305-22. PubMed ID: 19516252
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Ketamine increases striatal dopamine release and hyperlocomotion in adult rats after postnatal functional blockade of the prefrontal cortex.
    Usun Y; Eybrard S; Meyer F; Louilot A
    Behav Brain Res; 2013 Nov; 256():229-37. PubMed ID: 23958806
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Ketamine, at a dose that disrupts motor behavior and latent inhibition, enhances prefrontal cortex synaptic efficacy and glutamate release in the nucleus accumbens.
    Razoux F; Garcia R; Léna I
    Neuropsychopharmacology; 2007 Mar; 32(3):719-27. PubMed ID: 16525415
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The low-frequency blood oxygenation level-dependent functional connectivity signature of the hippocampal-prefrontal network in the rat brain.
    Schwarz AJ; Gass N; Sartorius A; Zheng L; Spedding M; Schenker E; Risterucci C; Meyer-Lindenberg A; Weber-Fahr W
    Neuroscience; 2013 Jan; 228():243-58. PubMed ID: 23098800
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Glutamate and schizophrenia: phencyclidine, N-methyl-D-aspartate receptors, and dopamine-glutamate interactions.
    Javitt DC
    Int Rev Neurobiol; 2007; 78():69-108. PubMed ID: 17349858
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Astrocyte DISC1 contributes to cognitive function in a brain region-dependent manner.
    Shevelkin AV; Terrillion CE; Hasegawa Y; Mychko OA; Jouroukhin Y; Sawa A; Kamiya A; Pletnikov MV
    Hum Mol Genet; 2020 Oct; 29(17):2936-2950. PubMed ID: 32803234
    [TBL] [Abstract][Full Text] [Related]  

  • 60. GMP prevents excitotoxicity mediated by NMDA receptor activation but not by reversal activity of glutamate transporters in rat hippocampal slices.
    Molz S; Tharine DC; Decker H; Tasca CI
    Brain Res; 2008 Sep; 1231():113-20. PubMed ID: 18655777
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.